Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Ulcerative esophagitis"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Advances in Digestive Medicine. 9:61-65
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::539e1f374ede8e0c1f2b1325014ad05a
https://doi.org/10.1002/aid2.13254
https://doi.org/10.1002/aid2.13254
Publikováno v:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 51(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdd8298f1c9ea0800684921dcc5c0241
https://pubmed.ncbi.nlm.nih.gov/30824406
https://pubmed.ncbi.nlm.nih.gov/30824406
Autor:
Durmuş Ali Çetin
Publikováno v:
Laparoscopic Endoscopic Surgical Science.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f47dc92905e0d93b786b9dbeaca6863d
https://doi.org/10.14744/less.2018.48030
https://doi.org/10.14744/less.2018.48030
Publikováno v:
American Journal of Gastroenterology. 114:S1000-S1000
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c753867c803723f958af0e0da36556f
https://doi.org/10.14309/01.ajg.0000596660.98089.64
https://doi.org/10.14309/01.ajg.0000596660.98089.64
Publikováno v:
ACG Case Reports Journal
Crizotinib is an oral tyrosine-kinase inhibitor that inhibits anaplastic lymphoma kinase (ALK) in gene-rearranged non-small cell lung cancer (NSCLC). In 2011, the Food and Drug Administration approved crizotinib for treatment of locally advanced or m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6686f9843990761cc47467c5a0a76a63
https://doi.org/10.14309/crj.2014.8
https://doi.org/10.14309/crj.2014.8
Publikováno v:
American Journal of Gastroenterology. 113:S1026
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d584e9a185ad40ca539ab1b250176154
https://doi.org/10.14309/00000434-201810001-01803
https://doi.org/10.14309/00000434-201810001-01803
Autor:
Gwenaelle Gravis, Fabrice Caillol, Marc Giovannini, Erwan Bories, Christian Pesenti, Odile Jeanniard-Malet
Publikováno v:
Journal of Gastrointestinal Cancer. 43:128-130
The development of SUTENT® revolutionized the care of metastatic renal carcinoma and of non-operable GIST. The tolerance is quite good with mostly mild side effects grade 1 or 2.We report the case of three severe esophagitis stage 4 responsible for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90241f6ab0952ee50c486648c8b9ab49
https://doi.org/10.1007/s12029-010-9171-y
https://doi.org/10.1007/s12029-010-9171-y
Autor:
Kjell Lundberg, Peter Unge, Bjørn Edwin, Lasse Carling, Ebbe Lyrenäs, B. Hallerbäck, Nilu Havu, H. Glise
Publikováno v:
Gastroenterology. 107:1305-1311
Background/Aims: Patients with reflux esophagitis have rapid relapses after treatment withdrawal. This study was designed to investigate the relapse rate of symptomatic esophagitis during maintenance treatment with omeprazole or ranitidine. Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab5bd31c60c7be66955f32b41d52ec01
https://doi.org/10.1016/0016-5085(94)90531-2
https://doi.org/10.1016/0016-5085(94)90531-2
Publikováno v:
Gastroenterology. 146:e9-e10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3aac0356abf062e97671719e2752614f
https://doi.org/10.1053/j.gastro.2014.01.010
https://doi.org/10.1053/j.gastro.2014.01.010